NEW YORK, Sept. 22, 2021 /PRNewswire/ -- The biosimilars market is poised to grow by USD 31.40 billion during 2021-2025, progressing at a CAGR of 25% during the forecast period, according to Technavio. The report offers an up-to-date analysis of the growth variance and the Y-O-Y growth rate.
The market is fragmented, and the degree of fragmentation will accelerate during the forecast period. Amgen Inc., Biogen Inc., Boehringer Ingelheim International GmbH, Eli Lilly and Co., F. Hoffmann-La Roche Ltd., Fresenius Kabi AG, Merck and Co. Inc., Novartis AG, Pfizer Inc., and Viatris Inc. are some of the major market participants. Although the price advantage of biosimilars over biologics will offer immense growth opportunities, market access barriers for biosimilars will challenge the growth of the market participants. To make the most of the opportunities, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments.
Related Reports on Health Care Include: Global Biosimilar Monoclonal Antibodies (mAbs) Market - Global biosimilar monoclonal antibodies (mAbs) is segmented by application (cancer and non-cancer) and geography (North America, Europe, Asia, and ROW). Download Exclusive Free Sample Report
Global Monoclonal Antibodies Market - Global monoclonal antibodies market is segmented by application (oncology, autoimmune disorders, infectious diseases, and other applications) and geography (North America, Europe, Asia, and ROW). Download Exclusive Free Sample Report
Biosimilars Market 2021-2025: Scope
Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources. Our biosimilars market report covers the following areas:
Biosimilars Market size
Biosimilars Market trends
Biosimilars Market industry analysis
This study identifies government initiatives to increase the use of biosimilar medicines as one of the prime reasons driving the biosimilars market growth during the next few years.
Biosimilars Market 2021-2025: Vendor Analysis We provide a detailed analysis of around 25 vendors operating in the Biosimilars Market. Backed with competitive intelligence and benchmarking, our research report on the Biosimilars Market is designed to provide entry support, customer profile, and M&As as well as go-to-market strategy support.
CAGR of the market during the forecast period 2021-2025
Detailed information on factors that will assist biosimilars market growth during the next five years
Estimation of the biosimilars market size and its contribution to the parent market
Predictions on upcoming trends and changes in consumer behavior
The growth of the biosimilars market
Analysis of the market's competitive landscape and detailed information on vendors
Comprehensive details of factors that will challenge the growth of biosimilars market vendors
Table Of Contents :
Value chain analysis
Market segment analysis
Market size 2020
Market outlook: Forecast for 2020 - 2025
Five Forces Analysis
Bargaining power of buyers
Bargaining power of suppliers
Threat of new entrants
Threat of substitutes
Threat of rivalry
Market Segmentation by Application
Comparison by Application
Oncology and hematology - Market size and forecast 2020-2025
Immunology - Market size and forecast 2020-2025
Endocrinology - Market size and forecast 2020-2025
Nephrology - Market size and forecast 2020-2025
Market opportunity by Application
Europe - Market size and forecast 2020-2025
Asia - Market size and forecast 2020-2025
North America - Market size and forecast 2020-2025
ROW - Market size and forecast 2020-2025
Key leading countries
Market opportunity by geography
Market positioning of vendors
Boehringer Ingelheim International GmbH
Eli Lilly and Co.
F. Hoffmann-La Roche Ltd.
Fresenius Kabi AG
Merck and Co. Inc.
Scope of the report
Currency conversion rates for US$
List of abbreviations
About Us Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.